Statistics for The hypolipidemic drug metabolites nafenopin-CoA and ciprofibroyl-CoA are competitive P2Y<sub>1</sub> receptor antagonists
Total visits
| views | |
|---|---|
| The hypolipidemic drug metabolites nafenopin-CoA and ciprofibroyl-CoA are competitive P2Y<sub>1</sub> receptor antagonists | 0 |
Total visits per month
| views | |
|---|---|
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |